MEPRIMET P 1 TABLET

Product Description

MEPRIMET P 1 TABLET is a powerful triple combination anti-diabetic formulation designed for effective Type 2 Diabetes Mellitus management. Each double color tablet contains Glimepiride 1mg, Metformin 500mg (Sustained Release), and Pioglitazone 15mg, working synergistically to improve glycemic control, enhance insulin sensitivity, and regulate blood sugar levels.Tailored for medical wholesalers, pharma retailers, clinic chains, and bulk medicine suppliers, MEPRIMET P 1 offers clinical reliability, cost efficiency, and high patient compliancemaking it a valuable addition to your anti-diabetic product portfolio.Key Benefits: Comprehensive blood sugar control through multi-mechanism action Sustained release formula of Metformin ensures long-lasting effect Promotes better insulin utilization and sensitivity Attractive double color tablet for improved patient adherence Manufactured in GMP-certified facilities ensuring safety and quality Therapeutic Use: Management of Type 2 Diabetes Mellitus Prescribed in endocrinology clinics, diabetes care centers, and primary care Suitable for long-term oral anti-diabetic therapy Why Choose MEPRIMET P 1 TABLET? High-quality anti-diabetic combination for optimized therapy Suitable for bulk supply to hospitals, distributors, and pharmacies Strong market demand in diabetic care segment Ready for B2B partnerships, contract manufacturing, and third-party labeling